ASND 128.66 (-0.95%)
US04351P1012BiotechnologyBiotechnology

Ascendis Pharma (ASND) Stock Highlights

128.66 | -0.95%
2024-10-22 00:19:58
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firms product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Statistics

Range Today
125.58 130.56
Volume Today 254.71K
Range 1 Year
85.29 161
Volume 1 Year 120.54M
Range 3 Year
61.58 167.11
Volume 3 Year 341.57M
Range 10 Year
11.92 183.98
Volume 10 Year 611.24M

Highlights

Market Capitalization 7.76B (mid)
Floating Shares 56.92M
Current Price 128.66
Price To Earnings -13.79
Price To Revenue 24.17
Earnings Per Share -9.39
Payout Ratio 0%

Performance

Latest -0.95%
1 Month -15.06%
3 Months -5.17%
6 Months -8.41%
1 Year +42.96%
3 Years -10.68%
5 Years +30.1%
10 Years +498.42%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.